Meeting
2019 ASCO Annual Meeting
Outcomes of extra-skeletal versus skeletal Ewing sarcoma patients treated with standard chemotherapy protocol.
Authors
Samer Salah
King Hussein Cancer Center, Amman, Jordan
Samer Salah , Fawzi Jamil Abuhijla , Taleb Ismaeel , Sameer Yaser , Iyad Yasin Sultan , Ahmad Shehadeh , Samer Abelal , Abdelatif Al-Mousa , Ramiz Abuhijlih
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Bone Tumors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 11027)
DOI
10.1200/JCO.2019.37.15_suppl.11027
Abstract #
11027
Poster Bd #
350
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg
Poster
2016 ASCO Annual Meeting
Prognostic value of tumor response in pediatric and adult patients with Ewing sarcoma.
First Author: Melanie Ann Chihak
Poster
2021 ASCO Annual Meeting
Comparison of treatment effect and long-term outcomes for pediatric and adult Ewing sarcoma patients in British Columbia, Canada.
First Author: Omar Hajjaj
Poster
2012 ASCO Annual Meeting
Intensive alternating 6-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma in children and adolescents: Impact on survival.
First Author: Gerges Attia Demian